全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

A Rare Etiology of Chronic Polyradiculoneuropathy: IgD Multiple Myeloma

DOI: 10.4236/oalib.1107818, PP. 1-6

Subject Areas: Neurology

Keywords: Immunoglobulin D, Multiple Myeloma, Polyardiculoneuropathy

Full-Text   Cite this paper   Add to My Lib

Abstract

Introduction: Immunoglobulin D multiple myeloma (IgD MM) is a rare entity of multiple myeloma (2%), characterised by its clinical severity, renal presentation and poor prognosis. IgD myeloma remains an exceptional cause of chronic polyradiculoneuropathy. Observation: A 54-year-old patient, known to have type 2 diabetes since 2016, was admitted in December 2020 for non-febrile obnubilation associated with tetraparesis. The interrogation noted the occurrence of a motor deficit of the four limbs for 4 months in connection with a sensitivemotor polyradiculoneuropathy of the axon-myelin type of the four limbs. Glasgow’s score was 10. Blood pressure was 130/80 mmHg, pulse 116 beats/min, temperature 37°C, SaO2 92% on room air, low capillary blood glucose 1.08 and oliguria 70 cc/H. The physical examination revealed meningeal syndrome, tetraparesis, anaemia and renal oedema. Investigations revealed severe hypercalcaemia (140 mg/L), purulent meningitis (purulent liquid CSF, 12.38 g/L protein, 0.52 g/L glycorrhaphy, 14/mm3 leucocytes, 2000/mm3 red blood cells) and acute renal failure (74 mg/L creatinine, 5 mL/min/m3 GFR, 2.65 mg/L urea). Symptomatic IgD multiple myeloma was suspected on the basis of bone marrow plasmacytosis, bilateral frontal diploid lacunar osteolysis on CT scan and IgD positivity. Conclusion: Our observation illustrates the possible plurality of symptoms of IgD MM, particularly chronic polyradiculoneuropathy which is a rare neurological sign that should not be ignored in order to avoid diagnostic errors.

Cite this paper

Seynabou, F. , Niang, E. H. D. , Khadim, S. , Badara, D. A. , Fatma, D. , Lolita, C. M. , Christian, C. , Aminata, D. , Awa, N. and Diago, N. F. S. (2021). A Rare Etiology of Chronic Polyradiculoneuropathy: IgD Multiple Myeloma. Open Access Library Journal, 8, e7818. doi: http://dx.doi.org/10.4236/oalib.1107818.

References

[1]  Mechtoune, M., Lahlimi, F.Z. and Tazi, I. (2021) Le myélome multiple à IgD: à propos d′un cas. PAMJ-Clinical Medicine, 6, Article No. 4. https://doi.org/10.11604/pamj-cm.2021.6.4.29094
[2]  Fall, S., Dieng, F., Diouf, C., Djiba, B., Ndao, A.C. and Ndiaye, F.S.D. (2017) Profil diagnostique et évolutif du myélome multiple au Sénégal: étude monocentrique de 2005 à 2016. Pan African Medical Journal, 8, Article No. 262. https://doi.org/10.11604/pamj.2017.27.262.13164
[3]  Kapoor, P., Rajkumar, S.V., Dispenzieri, A., Gertz, M.A., Lacy, M.Q., Dingli, D., et al. (2011) Melphalan and Prednisone versus Melphalan, Prednisone and Thalidomide for Elderly and/or Transplant Ineligible Patients with Multiple Myeloma: A Meta-Analysis. Leukemia, 25, 689-696. https://doi.org/10.1038/leu.2010.313
[4]  Benchekroun, L., Ouzzif, Z., Bouabdillah, M., Jaouhar, N., Aoufir, F., Aoufi, F., et al. (2011) Multiple Myeloma with D Immunoglobulin. Annales de Biologie Clinique, 69, 581-587. https://doi.org/10.1684/abc.2011.0617
[5]  Chakri, I. and Benchekroun, L. (2018) Myélome à IgD révélé par une insuffisance rénale: à Propos d’un cas. Journal Marocain des Sciences Médicales, 22, No. 1. https://doi.org/10.48401/IMIST.PRSM/jmsm-v22i1.17269
[6]  Amine, B., Benbouazza, K., Harzy, T., Rahmouni, R., Guedira, N., Lazrak, N., et al. (2004) Le myélome multiple à Ig D Kappa: Une nouvelle observation. Revue du Rhumatisme, 71, 617-619. https://doi.org/10.1016/j.rhum.2003.05.004
[7]  Said, G. (2006) Chronic Inflammatory Demyelinating Polyneuropathy. Neuromuscular Disorders, 16, 293-303. https://doi.org/10.1016/j.nmd.2006.02.008
[8]  Moussaid, R., El Mokhtari, M., Amjad, M. and Chraibi, A. (2014) Polyradiculonévrite chronique inflammatoire et neuropathie diabétique: Difficulté diagnostic et de prise en charge thérapeutique à propos d’un cas. Annales d’Endocrinologie, 75, Article 376. https://doi.org/10.1016/j.ando.2014.07.354
[9]  Poncet, J.C., Toussirot, E. and Wendling, D. (1997) Particularité du myélome à Immunoglobuline D. Revue du Rhumatisme, 64, 483-487.
[10]  Bartoloni, C., Flamini, G., Logroscino, C., Guidi, L., Scuderi, F., Gambassi, G., et al. (1980) IgD “No Secretory” Multiple Myeloma: Report of a Case. Blood, 56, 898-901. https://doi.org/10.1182/blood.V56.5.898.898
[11]  Afanasiev, V., Pottier, C., Benramdane, R., Precupanu, C., Cosma, D., Poll, R., et al. (2014) Méningite myélomateuse: Complication neurologique d’un myélome multiple. Revue Neurologique, 170, A64. https://doi.org/10.1016/j.neurol.2014.01.187
[12]  San Miguel, J.F., Blade Creixenti, J. and Garcia-Sanz, R. (1999) Treatment of Multiple Myeloma. Haematologica, 84, 36-58. https://doi.org/10.3324/%25x
[13]  Alcalay, M., Gombert, J., Frocrain, C. and Bontoux, D. (1975) Le myeloma IgD. à propos d’un cas. La semaine des hôpitaux, 51, 1227-1234.
[14]  Mayeur, D., Gruyer, P., Jarreau, C. and Dubrujeaud, J. (1992) Hypercalcémie révélatrice d’un myélome à IgD. La Presse Médicale, 21, Article No. 1774.
[15]  Bataille, R., Boccadoro, M., Kein, B., Durie, B. and Pileri, A. (1992) C-Reactive Proteinand ß 2 Microglobulin Produce a Simple and Powerful Myeloma Staging System. Blood, 80, 733-737. https://doi.org/10.1182/blood.V80.3.733.733

Full-Text


Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133